Skip to main content

fda_recall · drug_recall · critical

Baxter Healthcare Corporation — Class I recall: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusi…

Event date
2026-08-19 00:00:00Z
Observed
2026-09-08 04:20:24Z
Source ID
D-0787-2026
Payload hash
b2cc765845121a3585dd286b…

Summary

Presence of Particulate Matter Status: Ongoing.

Entities

View source record ↗

Frequently asked questions

Has Baxter Healthcare Corporation had other FDA enforcement actions?
Yes. Argus HQ has recorded 210 total FDA actions tied to Baxter Healthcare Corporation: 0 warning letters, 210 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?
This is an Argus HQ record of a FDA Recall, tagged critical severity by Argus HQ. FDA published the underlying record on 2026-08-19; Argus observed and indexed it on 2026-09-08.
Where can I verify this record directly with FDA?
The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA
Argus HQ Research (2026). Baxter Healthcare Corporation — Class I recall: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusi…. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-baxter-healthcare-corporation-d-0787-2026
MLA
"Baxter Healthcare Corporation — Class I recall: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusi…." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-recall-baxter-healthcare-corporation-d-0787-2026.
Chicago
Argus HQ Research. "Baxter Healthcare Corporation — Class I recall: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusi…." Digital Empire Holdings LLC. Accessed September 8, 2026. https://argushq.ai/events/fda-recall-baxter-healthcare-corporation-d-0787-2026.
BibTeX
@misc{argushq_argushq_ai_events_fda_recall_baxter_healthcare_corporation_d_0787_2026_2026,
  title = {Baxter Healthcare Corporation — Class I recall: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusi…},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-baxter-healthcare-corporation-d-0787-2026},
  note = {Accessed: September 8, 2026}
}

Informational only. Not legal, financial, or medical advice.

Baxter Healthcare Corporation — Class I recall: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusi… · Argus HQ